howdy, capt........supposed to get first/interim data for Insight-004 collaboration with pfizer/merck kgaa...
Combo trial with bavencio/avastin in Germany...I note first patient dosed 6th june this year...
also something to consider re:milestone payments.....
I note...Novartis are putting together 5 ph2 trials with imp701/ lag-525.....given that after GSK's recent
payment was attributed to ph2 first dosage of imp731 I think we can safely assume that Immutep SA's
outlicencing agreements involved payments on first dosage in specific phase trials.....ergo there is a
possibility of another m/s payment from novartis.....
left field news? .....dunno.....
Ann: Immutep expands Part A of TACTI-002 due to positive data, page-64
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $915.1K | 2.296M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 45266 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 253787 | 11 |
View Market Depth
| Last trade - 12.00pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |